Conversion to AbobotulinumtoxinA Increases Waning Time and Efficacy for Cervical Dystonia

Author:

Samotus Olivia12,Jog Mandar12

Affiliation:

1. Department of Clinical Neurological Sciences London Health Sciences Centre—Lawson Health Research Institute London Ontario Canada

2. Schulich School of Medicine and Dentistry University of Western London Ontario Canada

Abstract

ABSTRACTBackgroundSymptom re‐emergence before re‐injection negatively impacts cervical dystonia (CD) patients receiving botulinum toxin type A (BoNT‐A) therapy. Longer waning time is associated with abobotulinumtoxinA (abo‐BoNT‐A) as compared to onabotulinumtoxinA (ona‐BoNT‐A)/incobotulinumtoxinA (inco‐BoNT‐A) formulations.ObjectivesTo compare waning time and treatment outcomes when chronically injected CD patients experiencing early waning despite being optimized on BoNT‐A (ona‐BoNT‐A/inco‐BoNT‐A) were converted to abo‐BoNT‐A.MethodsThirty‐three chronically injected CD participants with a waning time of ≤8 weeks were converted to abo‐BoNT‐A (1:2.5 dose ratio) for three injections every 12‐weeks. The second and third injection patterns were kinematically optimized. Participants were converted back to their original BoNT‐A for the fourth injection (1:2.5) using the same third abo‐BoNT‐A pattern. Participant‐perceived waning times were collected post‐injections. Clinical scales (Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS)) and kinematic measures were collected 12‐weeks post‐injection and at three peak effect time‐points.ResultsCompared to baseline, waning time (12–22 days) significantly increased following all abo‐BoNT‐A treatments (P < 0.005) but was not significantly different at the fourth injection (original BoNT‐A reconversion). TWSTRS sub‐scores significantly reduced following all abo‐BoNT‐A treatments (P < 0.0001) and at peak effect following the third injection compared to original BoNT‐A. Dysphagia and muscle weakness were reported and comparable to safety of original BoNT‐A formulations.ConclusionsOptimized patients experiencing waning had significant improvement in the peak benefit as well as the duration of effect when converted to abo‐BoNT‐A. This effect was toxin dependent as reconversion to the original BoNT‐A using the kinematically optimized pattern failed to produce an improvement in waning.

Publisher

Wiley

Subject

Neurology (clinical),Neurology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3